July 24th 2025, 3:00pm
Adding SCIB1 or iSCIB1+ to standard treatments helped more patients with advanced melanoma respond and live longer without extra side effects.
July 24th 2025, 1:00pm
Ojjaara helps patients with myelofibrosis by reducing spleen size, easing symptoms, and improving anemia to boost independence from blood transfusions.
July 23rd 2025, 9:00pm
After ovary removal to prevent cancer, the sudden loss of estrogen reshaped my health and life, showing the need for better care and awareness for women like me.
July 23rd 2025, 8:00pm
Dr. Zhaoming Wang discussed how childhood cancer treatments can speed up biological aging and impact survivors’ health long after treatment ends.
July 23rd 2025, 7:00pm
Patients with high-risk bladder cancer reported similar quality of life when treated with sasanlimab plus BCG versus BCG alone, new study data showed.
July 23rd 2025, 5:00pm
I share my challenges and healing journey through colon cancer treatment, emphasizing mindset, self-healing and a newfound appreciation for life.
July 23rd 2025, 4:00pm
Adding casdatifan to Cabometyx therapy showed encouraging activity and was generally well tolerated in previously treated clear cell renal cell carcinoma.
July 23rd 2025, 3:00pm
The FDA granted fast track status to DB-1310, a HER3-targeting antibody-drug conjugate, for advanced nonsquamous non-small cell lung cancer.
July 23rd 2025, 1:00pm
Enabling patients to generate CAR T-cells internally could cut kidney cancer therapy costs, explained Dr. Wayne Marasco of Dana-Farber Cancer Institute.
July 22nd 2025, 9:00pm
Even six years after brain tumor surgery, invisible symptoms like brain fog and memory loss shape how I live, cope, and find gratitude every day.
Understanding Your Diagnosis of Bile Duct Cancer
Understanding Your Stage 2 Uterine (Endometrial) Cancer
Top Blood Cancer Stories from October: Key Updates for Patients
Expert Explains Need for Better Outcomes in Resectable Lung Cancer